SAMIL PHARMACEUTICAL CO.,LTD
Researches and manufactures pharmaceuticals with a focus on ophthalmology and CDMO services.
000520 | KO
Overview
Corporate Details
- ISIN(s):
- KR7000520007
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 효령로 155 (방배동, 삼일제약 사옥), 서초구
- Sector:
- Manufacturing
Description
Samil Pharmaceutical Co., Ltd. is a company engaged in the research, development, and manufacturing of pharmaceutical products. The company specializes in ophthalmology and also produces a diverse portfolio of drugs for other therapeutic areas, including the central nervous system (CNS), hepatic conditions, and gastrointestinal disorders. Its product range encompasses prescription medicines as well as over-the-counter remedies for common ailments like fever and colds. In addition to developing its own products, Samil Pharmaceutical offers Contract Development and Manufacturing Organization (CDMO) services to global partners. The company emphasizes research and development and collaborates with other leading pharmaceutical firms.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-11-15 00:00 |
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 13.2 KB | ||
| 2022-11-14 00:00 |
분기보고서 (2022.09)
|
Korean | 1.3 MB | ||
| 2022-10-28 00:00 |
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 11.7 KB | ||
| 2022-10-06 00:00 |
신탁계약해지결과보고서
|
Korean | 14.8 KB | ||
| 2022-10-04 00:00 |
주요사항보고서(자기주식취득신탁계약해지결정)
|
Korean | 23.4 KB | ||
| 2022-09-15 00:00 |
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 13.2 KB | ||
| 2022-08-12 00:00 |
반기보고서 (2022.06)
|
Korean | 1.3 MB | ||
| 2022-07-29 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 13.5 KB | ||
| 2022-07-28 00:00 |
유상증자또는주식관련사채등의발행결과(자율공시)
|
Korean | 5.6 KB | ||
| 2022-07-28 00:00 |
유상증자또는주식관련사채등의발행결과(자율공시)
|
Korean | 5.6 KB | ||
| 2022-07-28 00:00 |
자기주식처분결과보고서
|
Korean | 22.2 KB | ||
| 2022-07-26 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | 59.8 KB | ||
| 2022-07-26 00:00 |
주요사항보고서(교환사채권발행결정)
|
Korean | 33.8 KB | ||
| 2022-07-26 00:00 |
주요사항보고서(자기주식처분결정)
|
Korean | 30.5 KB | ||
| 2022-06-16 00:00 |
최대주주등소유주식변동신고서
|
Korean | 38.4 KB |
Automate Your Workflow. Get a real-time feed of all SAMIL PHARMACEUTICAL CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SAMIL PHARMACEUTICAL CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SAMIL PHARMACEUTICAL CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
